The Experts below are selected from a list of 198 Experts worldwide ranked by ideXlab platform
Jiwon Kwon - One of the best experts on this subject based on the ideXlab platform.
-
One-year outcome of Argon Laser photocoagulation of pinguecula.
Cornea, 2013Co-Authors: Seong Joon Ahn, Kyunghoon Shin, Won Ryang Wee, Mee Kum Kim, Jiwon KwonAbstract:Purpose:To determine the efficacy and safety of Argon Laser photocoagulation of pinguecula by evaluating 1-year outcomes.Methods:Twenty-one eyes of 15 patients treated with Argon Laser photocoagulation (photocoagulation group) and 23 eyes of 16 patients treated with surgical excision (excision group
-
new approach for conjunctivochalasis with Argon Laser photocoagulation
Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie, 2012Co-Authors: Kyunghoon Shin, Jaehyeong Hwang, Jiwon KwonAbstract:Abstract Objective To report a novel approach for conjunctivochalasis using Argon Laser photocoagulation. Design Noncomparative clinical interventional study. Participants We studied 5 eyes of 5 patients with epiphora due to conjunctivochalasis. Methods The patients underwent Argon Laser photocoagulation between April 2011 and July 2011 at Myongji Hospital. The preoperative and postoperative tear break-up time, tear meniscus height, conjunctivochalasis grading, and improvement of symptoms were evaluated. Results Most patients showed improvement of epiphora symptoms. No significant complications were observed during the follow-up period of more than 3 months. Conclusions Argon Laser photocoagulation is a simple and effective procedure for treating epiphora caused by conjunctivochalasis.
-
Argon Laser photoablation of conjunctival pigmented nevus
American Journal of Ophthalmology, 2006Co-Authors: Jin Wook Jeoung, Jiwon KwonAbstract:Purpose To evaluate the efficacy of an Argon Laser in the ablation of benign conjunctival pigmented nevi. Design Interventional case series. Methods We conducted Argon Laser ablations for conjunctival pigmented nevus in 30 eyes of 28 patients. Laser ablation was applied directly to the conjunctival pigmented nevus in all patients. All patients were followed up over a period of 12 months. Results In all patients, the conjunctival lesions to which the Argon Laser was applied disappeared almost completely within two days after treatment. No recurrence of lesions was detected in any patient during the follow-up period, nor were any conjunctival scars or conjunctival injections. Conclusions The Argon-Laser ablation of conjunctival pigmented nevi uniformaly resulted in excellent clinical outcomes. Therefore, this study concludes that Argon Laser ablation is a safe and effective modality for the treatment of benign conjunctival nevi, and this method could replace the classical surgical procedure.
Jin Wook Jeoung - One of the best experts on this subject based on the ideXlab platform.
-
Argon Laser photoablation of conjunctival pigmented nevus
American Journal of Ophthalmology, 2006Co-Authors: Jin Wook Jeoung, Jiwon KwonAbstract:Purpose To evaluate the efficacy of an Argon Laser in the ablation of benign conjunctival pigmented nevi. Design Interventional case series. Methods We conducted Argon Laser ablations for conjunctival pigmented nevus in 30 eyes of 28 patients. Laser ablation was applied directly to the conjunctival pigmented nevus in all patients. All patients were followed up over a period of 12 months. Results In all patients, the conjunctival lesions to which the Argon Laser was applied disappeared almost completely within two days after treatment. No recurrence of lesions was detected in any patient during the follow-up period, nor were any conjunctival scars or conjunctival injections. Conclusions The Argon-Laser ablation of conjunctival pigmented nevi uniformaly resulted in excellent clinical outcomes. Therefore, this study concludes that Argon Laser ablation is a safe and effective modality for the treatment of benign conjunctival nevi, and this method could replace the classical surgical procedure.
Georg Gerten - One of the best experts on this subject based on the ideXlab platform.
-
bevacizumab avastin and Argon Laser to treat neovascularization in corneal transplant surgery
Cornea, 2008Co-Authors: Georg GertenAbstract:Purpose:Two eyes with corneal neovascularization were treated with Argon Laser and bevacizumab (Avastin) to enhance transplant survival after penetrating keratoplasty.Patients and Methods:Before penetrating keratoplasty, pathologic corneal vessels were treated with Argon Laser coagulation and a simu
Feyzahan Ekici - One of the best experts on this subject based on the ideXlab platform.
-
Argon Laser-assisted treatment of benign eyelid lesions
Lasers in Medical Science, 2015Co-Authors: Şafak Korkmaz, Feyzahan EkiciAbstract:We investigated the treatment of benign eyelid lesions with Argon Laser as an alternative therapy to surgical excision. The charts of 73 patients with 95 lesions treated with Argon Laser photocoagulation were reviewed retrospectively. In all patients, the procedure was performed for cosmetic reasons. The Laser spot size ranged from 50 to 200 μm, the power varied from 300 to 700 mW, and the exposure time ranged between 0.1 and 0.2 s. The lesions were mostly located on the upper eyelid (66 %); the lid margin was involved in 30 cases. The mean follow-up time was 7.2 ± 3.5 months (range 3–15 months). A histopathological diagnosis was confirmed for 81 lesions (85.3 %). All patients were satisfied with the cosmetic result. No intraoperative complications occurred, and none of the patients complained of pain during Laser application. All wounds epithelialized in 3–4 weeks with skin that appeared normal. Hypopigmentation of the treated areas were observed in three cases. No recurrence occurred during the follow-up period. Argon Laser-assisted benign eyelid tumor excision is a useful, cheap, accessible, and well-tolerated alternative to traditional surgery.
Dai You - One of the best experts on this subject based on the ideXlab platform.
-
Clinical study of Argon Laser treatment for retinal holes
Recent Advances in Ophthalmology, 2001Co-Authors: Dai YouAbstract:Objective To evaluate the therapeutic efficiency of Argon Laser treatment for retinal holes Methods Two hundred and ninety two cases of retinal breaks without subretinal fluid and 113 cases of limited retinal detachment together with holes were treated by Argon Laser All patients were divided into some groups according to their age, sex, myopic diopter, the size and location of the hole were analysed Results All the patients with retinal breaks but without fluid were well treated by Argon Laser For patients with retinal detachment, the treatment outcomes were related with the hole location, morphology, size, as well as patients' age and myopic dioper Sex imposed no significant impact on the treatment results Conclusion The patients with retinal breaks, either without subretinal fluid or with limited retinal detachment should be treated by Argon Laser as early as possible, in order to prevent further retinal detachment If the retinal detachment excels 2PD, the patient is not fit for the Argon Laser treatment
